Biotech Showcase: Investor and Partnering Conference in San Francisco

The RESI conference takes place in San Francisco in January, in Toronto in April, in Boston in June & September, and in New York City in November. Fundraising CEOs have a venue to meet early stage investors that are a fit for their sector and stage every three months, providing a great ROI for cost conscious CEOs.

Every March, around 6,500 toxicologists and 350 exhibitors attend the SOT Annual Meeting and ToxExpo, the largest gathering of industry, governmental, and academic toxicologists in the world.

PDA’s Annual Meeting is one of the “can’t miss” events for 2018, offering a multifaceted look into the future of pharmaceutical manufacturing! At this year's meeting, speakers will focus their presentations on the end-user’s/patient perspective, innovative manufacturing strategies, disruptive technologies, and product value chain logistics. The increased use of Big Data, Artificial Intelligence, and robotics in the industry will also be explored.

CAT Week is the premier business development event for companies engaged in pharmaceutical development and manufacturing and related industries. It is organized and hosted by the Drug, Chemical & Associated Technologies Association (DCAT), a not-for-profit, member-supported, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies. Held annually in March, DCAT Week ensures that members have a forum for high-level strategic meetings with key decision makers, timely educational programs, and important networking opportunities.

The RESI conference takes place in San Francisco in January, in Toronto in April, in Boston in June & September, and in New York City in November. Fundraising CEOs have a venue to meet early stage investors that are a fit for their sector and stage every three months, providing a great ROI for cost conscious CEOs.

INTERPHEX is the premier pharmaceutical, biotechnology, and medical device development and manufacturing event where you can “Experience Science through Commercialization”. INTERPHEX succeeds in bringing together inspired professionals with key industry leaders to share knowledge and best practices, as well as see the latest cutting-edge technologies needed to cost-effectively develop and manufacture quality products.

CPhI is an established pharmaceutical event with over 26 years' experience of bringing together the movers and shakers in pharma. Uniting niche and top buyers and sellers together under one roof in nine event locations around the world, CPhI hosts quality conferences, free seminars, Awards and even pharma community charity expeditions!

The RESI conference takes place in San Francisco in January, in Toronto in April, in Boston in June & September, and in New York City in November. Fundraising CEOs have a venue to meet early stage investors that are a fit for their sector and stage every three months, providing a great ROI for cost conscious CEOs.

The June Land O’Lakes Conference on Formulation, Development and Drug Delivery is recognized worldwide as one of the premier teaching conferences for pharmaceutical scientists who want to learn about the latest trends and hot topics in formulation. This insightful, interactive annual gathering is an excellent way to advance your knowledge base and network with colleagues from around the globe.

This unique international conference will provide a platform for all pharmaceutical scientists, internists and primary care physicians to discuss important international breakthroughs in drug discovery and new therapeutics. The focus of the conference will be on the interdisciplinary fields of drug discovery, drug therapy and translational medicine.

This unique international conference will provide a platform for all pharmaceutical scientists, internists and primary care physicians to discuss important international breakthroughs in drug discovery and new therapeutics. The focus of the conference will be on the interdisciplinary fields of drug discovery, drug therapy and translational medicine.

The largest bioprocessing event bringing you the science, technologies and partners needed to accelerate promising biologics towards commercial success.

The RESI conference takes place in San Francisco in January, in Toronto in April, in Boston in June & September, and in New York City in November. Fundraising CEOs have a venue to meet early stage investors that are a fit for their sector and stage every three months, providing a great ROI for cost conscious CEOs.

ChemOutsourcing is the largest USA-based API and Pharmaceutical Ingredients show attracting annually 700-800 chemists, project management and business development personnel from the pharmaceutical, biotech, chemical, and chemistry services industries. The high level event focuses on API development spanning early drug discovery through chemical development and commercial supply.

The 17th Annual Contracting & Outsourcing Conference & Tabletop Exhibition will be held September 27-28, 2018 at Hyatt Regency New Brunswick, NJ, located in the heart of New Jersey’s pharmaceutical industry. The two-day conference and one-day exhibition on September 27th provides the perfect venue for easy, informal discussions for manufacturing, packaging, laboratory services and more! The tabletop exhibition will be held one day only on Thursday, September 27th with an additional half day of sessions held on Friday, September 28th.

PharmSci 360 has a dramatically different schedule and program than previous events. In basic terms, AAPS PharmSci 360 has five scientific tracks, and each track is split in half over biomolecular and chemical science. There will also be two topics – each could be thought of as a theme for the event -- running across all the tracks. 

The RESI conference takes place in San Francisco in January, in Toronto in April, in Boston in June & September, and in New York City in November. Fundraising CEOs have a venue to meet early stage investors that are a fit for their sector and stage every three months, providing a great ROI for cost conscious CEOs.